Two clinical trials of dementia care programs report negative results in terms of patient neuropsychiatric symptoms and ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...

Signs of mold toxicity mirror symptoms of common health nuisances...but a nationally recognized mold remediator says exposure ...

Use of montelukast not associated with risk of neuropsychiatric adverse events among children suggests a new study published in the JAMA.Spontaneous reports have indicated that ...

Systemic lupus erythematosus (SLE) often presents with neuropsychiatric (NP) involvement, including cognitive impairment and depression. Past magnetic resonance imaging (MRI) research in SLE patients ...

Their apathy levels were measured by the Neuropsychiatric Inventory (NPI)—a questionnaire that assesses 12 neuropsychiatric ...

Fowler, 43, a therapist in Chicago, has now shifted her practice to supporting clients who live with chronic and ...